©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 108551
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.108551
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.108551
Table 1 Clinical characteristics
| Characteristic | n = 611 |
| Age (years) | 60.7 ± 9.3 |
| Sex | |
| Male | 344 (56.3) |
| Female | 267 (43.7) |
| Body mass index (kg/m2) | 23.5 ± 3.3 |
| Smoking | 148 (24.2) |
| Drinking | 109 (17.8) |
| Hypertension | 173 (28.3) |
| Type 2 diabetes mellitus | 177 (29.0) |
| Albumin (g/L) | 41.8 ± 5.6 |
| Neutrophils (× 109/L) | 4.2 ± 2.0 |
| Lymphocytes (× 109/L) | 1.6 ± 0.6 |
| Advanced lung cancer inflammation index | 44.0 ± 23.5 |
| Tumor location | |
| Pancreatic head and neck | 315 (51.6) |
| Pancreatic body and tail | 296 (48.4) |
| TNM stage | |
| I | 306 (50.1) |
| II | 158 (25.9) |
| III | 147 (24.1) |
| Tumor size (cm) | 3.8 ± 1.6 |
| Operation time (min) | 251.0 ± 112.0 |
| Blood loss (mL) | 411.7 ± 476.4 |
| Hospital stays (days) | 16.8 ± 10.3 |
- Citation: Wen ZL, Ren H, Fei H, Niu PH, Li ZF, Chen YT, Guo CG, Zhao DB. Prognostic significance of advanced lung cancer inflammation index in resectable pancreatic cancer: A retrospective study. World J Gastrointest Surg 2025; 17(9): 108551
- URL: https://www.wjgnet.com/1948-9366/full/v17/i9/108551.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i9.108551